Open AccessA glance on a problem of comorbid conditions touched upon in the national agreement on treatment and diagnostics of COPD from the viewpoint of personal experience. Disccussion over decree no.555
Author(s) -
Yuriy Mostovoy,
Л. В. Распутіна,
Alina Dovgan,
M Ovcharuk
Publication year - 2014
Publication title -
bukovinsʹkij medičnij vìsnik
Language(s) - English
Resource type - Journals
eISSN - 2413-0737
pISSN - 1684-7903
DOI - 10.24061/2413-0737.xviii.3.71.2014.172
Subject(s) - copd , comorbidity , medicine , diabetes mellitus , disease , pulmonary disease , intensive care medicine , physical therapy , endocrinology
The purpose of the study was to analyze the prevalence of comorbid pathologies in patients with chronic obstructive pulmonary disease (COPD) and the effect of comorbidity on the course of disease in the light of existing recommendations on supervision of COPD patients and from the standpoint of our own experience. We made an analysis of prevalence of arterial hypertension, coronary heart disease, diabetes mellitus, and psychosomatic disorders in patients with COPD. The analysis of the world data revealed that comorbidity in patients with COPD was diagnosed much less frequently, which may be preconditioned with the problems of under-diagnosis for COPD itself. At the same time, patients with comorbid conditions were diagnosed a number of serious clinical syndromes that predetermined the course and severity of the disease. Administration of beta-blockers to patients with COPD is effective and safe and may positively influence the prognosis for those patients.